The strong electric field created by plasmons in the
surface or
tip-enhanced Raman scattering (SERS or TERS)-based detection of ultralow
organic and biological molecules finds limited success in the case
of inorganic molecules such as SnO2. Our report highlights
the fabrication of a highly efficient Ag SERS substrate as the first
direct evidence of the Raman A1g mode in rutile SnO2 quantum dots (QDs). SnO2 QDs show an uncharacteristic
and broad Raman feature around 575 cm–1. First,
the fabrication of an ultraefficient SERS substrate with a huge electric
field enhancement is demonstrated with a display of single-molecule
detection of rodamine6G (R6G) molecules (∼10–18 M), which is supported by finite-difference time-domain (FDTD) calculations.
These efficient SERS substrates as nanonets help reveal, for the first
time, the A1g mode at 627 cm–1 in QDs
with a red shift from 633 cm–1 of the bulk SnO2. This observation is further supported by a high-pressure
Raman study. Notably, these SERS substrates have allowed further observation
of an intense IR-active Eu (TO) mode as a Raman mode for
crystalline SnO2 of 25 nm size. Such an exclusive appearance
of an IR is explained by the gradient-field Raman (GFR) effect instead
of the previously employed mutual exclusion principle breakdown theory.
This proposition is well supported by Fourier transfer infrared (FTIR)
and temperature-dependent Raman spectroscopic measurements.
Adsorption and photocatalysis processes are considered of high significance for the remediation of toxic dye in aquatic medium. Herein, we report a remarkable performance of uncapped SnO2 quantum dots (QDs)...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.